Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00916981
Other study ID # ref:2006-73
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received June 3, 2009
Last updated February 22, 2012
Start date November 2008
Est. completion date June 2009

Study information

Verified date February 2012
Source University Hospital of Liege
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Treatment of nonunion, delayed union and malunion fractures of long bones remains problematic. The definition of nonunion is a failure of the fracture to heal in six months in a patient in whom progressive repair had not been observed radiographically between the third and sixth month after the fracture. First of all good surgical techniques are stable immobilization must be obtained and local sepsis excluded. Then stimulation of the callus is required. Numerous techniques have been developed ranging from invasive interventions (including internal fixation with the use of bone graft or bone graft substitutes) to non invasive procedures (ultrasound and pulsed electromagnetic fields).

Recently, autologous cell therapy was presented as an interesting approach. The concept of such therapies is based on the effect of stem cells presented in the bone marrow and able to be transformed in osteoblast cells. The percutaneous technique of autologous bone-marrow grafting is a minimally invasive alternative able to produce a good healing of the fracture. The efficacy is dependent of the concentration in progenitor cell reinjected. An optimization of this type of treatment could be achieved using a technique to increase the differentiation of the bone marrow cells in preosteoblasts before the injection in situ by an adequate culture. Therefore we would like to start a pilot open study on the feasibility and the efficacy of implantation of preosteoblasts into nonunion. Two different presentations exist: the atrophic and the hypertrophic pseudarthrosis in relationship with radiological features of bone proliferation at the tip of bone fragments. Some data support that atrophic and hypertrophic nonunion fractures could have different physiopathological factors. So, in a first time we only would evaluate the atrophic form and to determine in an open study the effect of the implantation of preosteoblasts into atrophic nonunion.


Description:

We will recruit 30 patients having a atrophic nonunion fracture of long bone present for minimum 6 months.50 ml of bone marrow harvest will be performed under local anaesthesia 3 weeks before the implantation. After three weeks of culture, preosteoblastic cells will be injected into the site of pseudarthrosis under radioscopic control, using percutaneously a 3 mm trephine.

An immobilization and non weight-bearing of the bone will be respected during the first month after the injection. If callus could be observed on radiographs, partial mobilization and weight-bearing will be allowed during the second month.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date June 2009
Est. primary completion date June 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Fracture of a long bone having insufficient healing after minimum 6 months.

- Be able and willing to participate in the study.

Exclusion Criteria:

- Evidence of malignant disorder in the past five year.

- Patient who is positive for an HIV, hepatitis B or C infection.

- Insufficient reduction of the fracture with displaced fragments.

- Evidence of local sepsis by biological parameters and/or positive isotopic scan using leucocytes labelled by Indium.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
percutaneous autologous preosteoblast cells implantation
percutaneously injection of preosteoblast into the nonunion under radioscopic control

Locations

Country Name City State
Belgium CHU Sart Tilman Liege Liège

Sponsors (1)

Lead Sponsor Collaborator
Jean-Philippe Hauzeur

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary radiological progression of bone fusion monthly 1, 2, 3, 4, 5, 6 months No
Secondary reduction of pain using VAS each month Yes
See also
  Status Clinical Trial Phase
Recruiting NCT03970941 - Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis
Terminated NCT01461005 - A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) N/A
Terminated NCT00424567 - Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures. Phase 1/Phase 2
Completed NCT04200872 - Observational Retrospective Study on the Clinical and Radiographic Outcomes of the Aseptic Pseudarthrosis Treatment of the Upper Limb
Recruiting NCT05583864 - Lumbar Fusion With Porous Versus Non-Porous Cages N/A
Recruiting NCT05483387 - Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments. Phase 4
Completed NCT04418882 - Septic Management and Outcome of Open Fracture
Not yet recruiting NCT01756144 - rhBMP-2 vs Autologous Bone Grafting for the Treatment of Non-union of the Docking Site in Tibial Bone Transport N/A
Enrolling by invitation NCT06103396 - Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs) Phase 1/Phase 2
Terminated NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Recruiting NCT06098157 - Tuebingen Register of Union Failure After Fractures of the Upper and Lower Extremities
Recruiting NCT02683252 - Musculoskeletal Non-tumoral Pathology Quantitative Perfusion N/A
Completed NCT00726128 - Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System